Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT06454110 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06454110
- Sponsor
- NovelMed Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2028-02-01
- Primary completion
- 2030-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.